Janeen Noel Doyle - May 14, 2025 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Role
Chief Corp. & Bus. Dev. Ofcr
Signature
/s/ James Pennington, Attorney-in-Fact
Stock symbol
JANX
Transactions as of
May 14, 2025
Transactions value $
$0
Form type
3
Date filed
5/23/2025, 08:02 PM
Next filing
Jun 4, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr C/O JANUX THERAPEUTICS, INC., 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO /s/ James Pennington, Attorney-in-Fact 2025-05-23 0002069239

No securities are beneficially owned.